Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial
在老年转移性结直肠癌患者中，FOLFIRI-aflibercept诱导治疗后使用5-FU/LV-aflibercept维持治疗与FOLFIRI-aflibercept治疗至疾病进展作为二线治疗的比较：AFEMA II期随机试验
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103986
García-Alfonso, P; Elez, E; Soto-Alsar, J; Páez, D; Fernández-Montes, A; Graña, B; Salud, A; Yubero, A; Gómez-España, M A; Macías, I; Quintero, G; López-López, C; Fernández-Rodríguez, T; Grávalos, C; González-Flores, E; Guix, M; García Paredes, B; Reina, J J; Rodríguez Mowbray, J R; Sastre, J; Aranda, E
